Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30730095 | 0.81 | ALDH1A1 (0.41) | ALDH1A1GAARAB9A | |
| SCHEMBL908480 | 0.80 | NR1H2 (0.34) | ALDH1A1ATML3MBTL1TDP1NR1H2 | |
| SCHEMBL12879029 | 0.79 | ALDH1A1 (0.40) | ALDH1A1ATML3MBTL1GAARAB9A | |
| SCHEMBL22637774 | 0.75 | GAA (0.38) | ALDH1A1ATML3MBTL1GAARAB9A | |
| SCHEMBL31206453 | 0.74 | GAA (0.33) | ALDH1A1ATML3MBTL1GAATDP1 | |
| SCHEMBL30730019 | 0.70 | LMNA (0.44) | SMN1; SMN2 | |
| SCHEMBL4884851 | 0.69 | CYP1A2 (0.40) | ALDH1A1NR1H2RAB9ASMN1; SMN2 | |
| SCHEMBL12410988 | 0.68 | SMN1; SMN2 (0.47) | ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL975064 | 0.68 | SMN1; SMN2 (0.47) | ALDH1A1ATML3MBTL1GAARAB9A | |
| SCHEMBL12307408 | 0.68 | STING1 (0.44) | ALDH1A1GAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562015-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024026481-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |